GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Senhwa Biosciences Inc (ROCO:6492) » Definitions » Policy Acquisition Expense

Senhwa Biosciences (ROCO:6492) Policy Acquisition Expense


View and export this data going back to 2014. Start your Free Trial

What is Senhwa Biosciences Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Senhwa Biosciences Business Description

Traded in Other Exchanges
N/A
Address
Peihsin Road, 10th Floor, No. 225, Section 3, Hsintien District, New Taipei, TWN, 23143
Senhwa Biosciences Inc is engaged in the development of new drugs and special pharmaceutical ingredients focusing on human efficacy. The company's product pipeline includes Pidnarulex (CX-5461), Silmitasertib (CX-4945), and Silmitasertib (for Moderate Covid-19). All of its revenue comes from Taiwan.